GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beta Drugs Ltd (NSE:BETA) » Definitions » Asset Turnover

Beta Drugs (NSE:BETA) Asset Turnover : 0.66 (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Beta Drugs Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Beta Drugs's Revenue for the six months ended in Sep. 2024 was ₹1,803 Mil. Beta Drugs's Total Assets for the quarter that ended in Sep. 2024 was ₹2,743 Mil. Therefore, Beta Drugs's Asset Turnover for the quarter that ended in Sep. 2024 was 0.66.

Asset Turnover is linked to ROE % through Du Pont Formula. Beta Drugs's annualized ROE % for the quarter that ended in Sep. 2024 was 28.92%. It is also linked to ROA % through Du Pont Formula. Beta Drugs's annualized ROA % for the quarter that ended in Sep. 2024 was 17.82%.


Beta Drugs Asset Turnover Historical Data

The historical data trend for Beta Drugs's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beta Drugs Asset Turnover Chart

Beta Drugs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.96 1.03 1.34 1.28 1.31

Beta Drugs Semi-Annual Data
Mar13 Mar14 Mar15 Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.68 0.61 0.65 0.63 0.66

Competitive Comparison of Beta Drugs's Asset Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Beta Drugs's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beta Drugs's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beta Drugs's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Beta Drugs's Asset Turnover falls into.


;
;

Beta Drugs Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Beta Drugs's Asset Turnover for the fiscal year that ended in Mar. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=2957.138/( (1984.215+2540.986)/ 2 )
=2957.138/2262.6005
=1.31

Beta Drugs's Asset Turnover for the quarter that ended in Sep. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=1803.034/( (2540.986+2945.062)/ 2 )
=1803.034/2743.024
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Beta Drugs  (NSE:BETA) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Beta Drugs's annulized ROE % for the quarter that ended in Sep. 2024 is

ROE %**(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=488.728/1689.887
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(488.728 / 3606.068)*(3606.068 / 2743.024)*(2743.024/ 1689.887)
=Net Margin %*Asset Turnover*Equity Multiplier
=13.55 %*1.3146*1.6232
=ROA %*Equity Multiplier
=17.82 %*1.6232
=28.92 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2024) net income data. The Revenue data used here is two times the semi-annual (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Beta Drugs's annulized ROA % for the quarter that ended in Sep. 2024 is

ROA %(Q: Sep. 2024 )
=Net Income/Total Assets
=488.728/2743.024
=(Net Income / Revenue)*(Revenue / Total Assets)
=(488.728 / 3606.068)*(3606.068 / 2743.024)
=Net Margin %*Asset Turnover
=13.55 %*1.3146
=17.82 %

Note: The Net Income data used here is two times the semi-annual (Sep. 2024) net income data. The Revenue data used here is two times the semi-annual (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Beta Drugs Asset Turnover Related Terms

Thank you for viewing the detailed overview of Beta Drugs's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Beta Drugs Business Description

Traded in Other Exchanges
N/A
Address
SCO-184, First Floor, Sector-5, Panchkula, HR, IND, 134114
Beta Drugs Ltd operates in the pharmaceutical industry. The company manufactures and sells Oncology products in the form of tablets, capsules, oral formulations, and injections. It sells the products in India and also exports them to other countries of which key revenue is derived from the sales made in India.

Beta Drugs Headlines

No Headlines